Markets traded range-bound on April expiry day amid global selling pressure and weak FMCG earnings; analysts expect continued ...

Benchmark NSE Nifty50 index was down 35.96 points at 24293.0, while the BSE Sensex was down 126.34 points at 79990.15. Among ...

The US Court of Appeals has vacated a preliminary injunction that had stalled Sun Pharma’s launch of Leqselvi in the U.S., a move analysts see as a key positive for the company. Emkay Global Financial ...

Sun Pharma share price: Pharmaceutical company Sun Pharma shares were buzzing in trade on the last trading day of the week i.e. Friday, April 11, 2025. The rise in the Sun Pharma share price came ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global players ...

Nifty Pharma has fallen by 12.8 per cent so far this year, with Natco Pharma and Granules India leading the plunge ...

9th Apr 2025 10:22 am RNS Form 8.5 (EPT/RI) - Alliance Pharma plc 9th Apr 2025 9:05 am GNW Form 8.5 (EPT/RI) - Alliance Pharma plc ...

Indian pharma stocks, including Sun Pharmaceutical Industries, Gland Pharma, Lupin and others traded sharply lower on Wednesday after the US President Donald Trump said he will soon announce a ...

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px&apos ...

Natco Pharma said. “Subject to the foregoing, the company has decided to price the product at ₹15,900 MRP... the company also intends to offer discount to certain deserving patients through ...

Natco Pharma on Tuesday shared a legal ... ratio of 7.87 against a price-to-book (P/B) value of 2.04. Earnings per share (EPS) stood at 98.90 with a return on equity (RoE) of 25.89.